Abstract:Abstract Background Novartis and the University of Oxford’s Big Data Institute (BDI) have established a research alliance with the aim to improve health care and drug development by making it more efficient and targeted. Using a combination of the latest statistical machine learning technology with an innovative IT platform developed to manage large volumes of anonymised data from numerous data sources and types we plan to identify novel patterns with clinical relevance which cannot be detected by humans alone to identify phenotypes and early predictors of patient disease activity and progression. Method The collaboration focuses on highly complex autoimmune diseases and develops a computational framework to assemble a research-ready dataset across numerous modalities. For the Multiple Sclerosis (MS) project, the collaboration has anonymised and integrated phase II to phase IV clinical and imaging trial data from ≈35,000 patients across all clinical phenotypes and collected in more than 2200 centres worldwide. For the “IL-17” project, the collaboration has anonymised and integrated clinical and imaging data from over 30 phase II and III Cosentyx clinical trials including more than 15,000 patients, suffering from four autoimmune disorders (Psoriasis, Axial Spondyloarthritis, Psoriatic arthritis (PsA) and Rheumatoid arthritis (RA)). Results A fundamental component of successful data analysis and the collaborative development of novel machine learning methods on these rich data sets has been the construction of a research informatics framework that can capture the data at regular intervals where images could be anonymised and integrated with the de-identified clinical data, quality controlled and compiled into a research-ready relational database which would then be available to multi-disciplinary analysts. The collaborative development from a group of software developers, data wranglers, statisticians, clinicians, and domain scientists across both organisations has been key. This framework is innovative, as it facilitates collaborative data management and makes a complicated clinical trial data set from a pharmaceutical company available to academic researchers who become associated with the project. Conclusions An informatics framework has been developed to capture clinical trial data into a pipeline of anonymisation, quality control, data exploration, and subsequent integration into a database. Establishing this framework has been integral to the development of analytical tools.

A new paradigm for accelerating clinical data science at Stanford Medicine

The Stanford Medicine data science ecosystem for clinical and translational research

A Scalable Data Science Platform for Healthcare and Precision Medicine Research

A framework for sharing of clinical and genetic data for precision medicine applications

A Methodology for a Scalable, Collaborative, and Resource-Efficient Platform to Facilitate Healthcare AI Research

A highly scalable repository of waveform and vital signs data from bedside monitoring devices

An Intelligent Search & Retrieval System (IRIS) and Clinical and Research Repository for Decision Support Based on Machine Learning and Joint Kernel-based Supervised Hashing

Building a collaborative cloud platform to accelerate heart, lung, blood, and sleep research

Advancing clinical cohort selection with genomics analysis on a distributed platform

A Health Care Clinical Data Platform for Rapid Deployment of Artificial Intelligence and Machine Learning Algorithms for Cancer Care and Oncology Clinical Trials

A Case Study for a Big Data and Machine Learning Platform to Improve Medical Decision Support in Population Health Management

Achieving Inclusive Healthcare through Integrating Education and Research with AI and Personalized Curricula

Compliant Self Service Access to Secondary Use Clinical Data at Stanford Medicine

Optimizing Clinical Workflow Using Precision Medicine and Advanced Data Analytics

Unlocking biomedical data sharing: A structured approach with digital twins and artificial intelligence (AI) for open health sciences

The Stanford Data Miner: a novel approach for integrating and exploring heterogeneous immunological data

Sociome Data Commons: A scalable and sustainable platform for investigating the full social context and determinants of health

Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis

Towards a Real-Time Big Data Analytics Platform for Health Applications.

Beyond the hype of big data and artificial intelligence: building foundations for knowledge and wisdom

Patient-centered data science: an integrative framework for evaluating and predicting clinical outcomes in the digital health era